reports
- GlobalData Healthcare Department
Sun BioPharma Inc (SNBP) - Financial Analysis Review
Sun BioPharma Inc (SNBP) - Financial Analysis Review Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc, is a biopharmaceutical company developing disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products portfolio includes SBP-101 for the treatment of pancreatic ductal adenocarcinoma, a common type of pancreatic cancer and is in phase I clinical trial. GlobalData's Sun BioPharma Inc (SNBP) - Financial Analysis Review ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.